Cellbricks

Cellbricks

Biotechnologie

Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice

Info

At Cellbricks, we are committed to make a significant impact on the lives of millions of patients dealing with compromised organ function. We achieve this through the innovative production of bioprinted tissue therapeutics, offering humans longer and healthier lives by restoring or supporting organ function. Cellbricks is a biotech company, combining world-leading expertise in synthetic biology and 3D-bioprinting. Leveraging our proprietary biofabrication technology and our tissue engineering proficiency, we are replicating human tissue at scale so researchers and doctors can provide patients with better clinical treatments. Our rapidly growing, multi-disciplinary team consists of biotech enthusiasts, scientists, PhDs, engineers, chemists and entrepreneurs from excellent universities and top companies from all over the world. Our labs and offices are located in Berlin, Europe's start-up capital. For inquiries please contact: Moritz Marschall mm@cellbricks.com

Branche
Biotechnologie
Größe
11–50 Beschäftigte
Hauptsitz
Berlin
Art
Privatunternehmen
Gegründet
2016
Spezialgebiete
3D Bioprinting, Bioink, Biotechnology, Tissue engineering, Breast cancer, Regenerative medicine, LabModels, Recombinant Collagen, TechBio, Oncology, Pharma, Lifesciences, HealthTech, Biologics, Implants, Autologous Tissue Implants, Breast Reconstruction, Stereolithography, Human Tissue und tissue therapeutics

Orte

  • Primär

    Müllerstrasse 178

    c/o Campus of Bayer AG

    Berlin, 13353, DE

    Wegbeschreibung

Beschäftigte von Cellbricks

Updates

Ähnliche Seiten

Jobs durchsuchen